DeviceAlliance: MedTech Radio
Join us on DeviceAlliance's Podcast: MedTech Radio where we interview today's brightest minds in Southern California's medical device industry. Each episode deconstructs complex topics and provides the tactics, tools, and strategies to overcome tomorrow's challenges. DeviceAlliance strives to be the one-stop-shop at the center of the medical device ecosystem helping drive collaboration, innovation, and career development for all device professionals in Southern California.
info_outline
Juliana Elstad: The Grand Strategy | Ep.54
09/21/2023
Juliana Elstad: The Grand Strategy | Ep.54
Juliana Elstad is the President, CEO of Vibrato Medical. She is a global executive with significant experience identifying opportunities for growth and delivering success in start-ups to multi-billion-dollar companies, and has led innovative medical companies through compelling vision, strategy, and growth. She has worked both in start-ups and Fortune 500 corporations in the U.S. and Emerging Markets and has worn many leadership “hats” in the medical device business. She serves as a board member of AdvaMed Accel, the world’s largest trade association representing medical device and diagnostics manufacturers. AdvaMed Accel is the division within AdvaMed dedicated to addressing the needs and challenges of smaller innovative medical device and diagnostics manufacturers – the lifeblood of the medical technology industry. Advamed is powering the MedTech Conference in Anaheim, California, October 9-11, 2023. Featuring world-class speakers, a cross-cutting educational program, invaluable networking and next-level technology, this forum for transformational ideas is a can’t-miss event for the industry’s prominent and most promising companies. Learn more at:
/episode/index/show/devicealliancepodcast/id/28103750
info_outline
Bill Colone: The One Thing | Ep.53
07/19/2023
Bill Colone: The One Thing | Ep.53
MedTech startups found themselves flush with cash a couple of years ago for quite obvious reasons. Pandemic-fuelled investment pushed VC funding for medtech and health-focused companies to unforeseen heights. But times have certainly changed. The medical device industry now finds itself reckoning from the banking crisis and VCs shifting priorities (and funds) towards other opportunities. That shift has caused funding for early-stage medtech companies to decline significantly, with numbers sliding by the billions across the board for digital health projects. Entrepreneurs and developers in MedTech will have to shift their focus on projects that either address the most common pain points in healthcare or projects that bridge different industries to create innovative healthcare solutions. What are the best strategies to do this during times like these? Today's guest is the CEO of Single Pass, Bill Colone. He is an experienced medical device executive with expertise in investor presentations, fund raising, building teams, product development, operations management, Class II and Class III Medical Device clinical trials, start-up organizations, and hands-on experience with peripheral cardiovascular devices from concept through commercialization. He is a seasoned entrepreneur, and MedTech executive who has held past roles as General Partner of Quantum Fund, CEO of Spinal Singularity, VP of R&D at Direct Flow Medical, Director of R&D at Endologix, and President and CEO of Arizona Heart Innovative Technologies. Join us for a lively discussion on the life lessons he's learned as a MedTech entrepreneur, the most important aspects of creating a start-up team, the best strategies for emerging MedTech companies in challenging economic times, and what Orange County needs to do to become a global medical device leader.
/episode/index/show/devicealliancepodcast/id/27505689
info_outline
Roger Holmes: Reaching Across the Pond | Ep.52
09/13/2022
Roger Holmes: Reaching Across the Pond | Ep.52
In an ideal world, no one would have a catheter, but the reality is that 100M patients worldwide rely on an indwelling urinary catheter. Catheterized patients often experience problems, such as catheter-associated urinary tract infections (CAUTI), catheter blockages, leaking and bladder spasms. FLUME estimates the healthcare burden of Foley catheter complications to be equivalent to $80 on average, for each of the 28m placed annually in the US - a total burden of around $2.2bn - and close to $60 even for short term placement. Join Co-Founder & Chief Executive at The Flume Catheter Company Limited Roger Holmes, and DeviceAlliance MedTech Radio Host Scott Johnson as they discuss.... - The catheter problem impacting 100M people - The 2.2B burden in the U.S. - Flume Catheter's goal to impact millions for a philanthropic purpose - Roger's life lessons in entrepreneurship
/episode/index/show/devicealliancepodcast/id/24362082
info_outline
Monica Pleasant: The Great Realignment | Ep.51
05/02/2022
Monica Pleasant: The Great Realignment | Ep.51
It's been almost a year since Anthony Klotz, a psychologist and professor of business administration at Texas A&M University, coined a famous phrase when he said “the great resignation is coming” in an interview with Bloomberg Businessweek. The popular phrase refers to the elevated level in early 2022 coming off a year in which almost 48 million people quit their jobs, an annual record. As one can imagine, this revolution of sorts has caused quite a stir amongst the HR Community, with experts scrambling to understand the "why" behind this mass exodus…and work out what it is that employees actually want. Join us as we discuss the misconceptions of the Great Resignation from the employee and employer perspective, the mistakes that companies are making to address employee engagement, best shared practices adapting to our new norms, and the strategic considerations for small to large scale MedTech companies building their workforce.
/episode/index/show/devicealliancepodcast/id/22984994
info_outline
William Curtis: Driving Diagnostic Excellence | Ep.50
03/23/2022
William Curtis: Driving Diagnostic Excellence | Ep.50
/episode/index/show/devicealliancepodcast/id/22550738
info_outline
Osman Khawar: Consumer Centric Dialysis | Ep.49
03/08/2022
Osman Khawar: Consumer Centric Dialysis | Ep.49
Today we speak with CEO of Diality, Osman Khawar. Diality is a privately held medical device company currently in development of a versatile hemodialysis machine useable at home or in a variety of care settings, including nursing homes, hospitals, transitional care facilities and dialysis centers*. Committed to helping build a future where all patients and partners can control kidney disease, Diality is focused on developing solutions that help care providers improve the care and lives of patients with kidney disease while giving physicians the flexibility to prescribe personalized dialysis treatments regardless of delivery setting. Join us as we discuss the current status of dialysis treatment, the burdens of treatments, the evolution toward consumer centric dialysis, and how the opportunity for innovation can improve the distinct needs of dialysis providers across all segments of the market.
/episode/index/show/devicealliancepodcast/id/22380764
info_outline
Ramin Mousavi: Innovation Leadership Mindset | Ep.48
01/25/2022
Ramin Mousavi: Innovation Leadership Mindset | Ep.48
Ramin Mousavi is the CEO, President, and Board of Directors for Cathworks; a medical technology company focused on applying its advanced computational science platform to optimize Coronary Artery Disease (CAD) therapy decisions and elevate coronary angiography from visual assessment to an objective FFR-based decision-making tool for physicians. Ramin has executive leadership and operational experience in general management, marketing, strategy, product development, and commercialization across multiple market segments and was responsible for developing the clinical and commercial strategy for CathWorks. He helped with the regulatory clearance of the product in Europe, United States and Japan. He also led the company’s Global Health Economic & Reimbursement strategy where the company was successful in receiving reimbursements in the US and Japan. He is leading the way in building an innovative and community-based organization with a mission to provide clinicians with objective data, so they can make the best decisions for their patients. Join us as we discuss the unmet clinical needs for coronary artery disease, Cathworks journey to understanding the physician perspective, Ramin's personal leadership journey, the advancement of computational science, the economic benefits for patients and payers, the evolution of innovation, and much more!
/episode/index/show/devicealliancepodcast/id/21892052
info_outline
Kristy J. Kennedy: The Changing Tide of Medtech Marketing | Ep.47
01/11/2022
Kristy J. Kennedy: The Changing Tide of Medtech Marketing | Ep.47
Your Medtech brand is not something an agency gives to you. Nor is it something you buy. Your brand is defined by the relationship you have with your customers, and it’s shaped by the messages you send and the response those messages elicit. Getting the attention of busy physicians and hospital executives is more challenging than ever for medical device manufacturers across the globe. Doctors are busier and have less time to see patients, let alone talk to a sales representative. Successful medical device marketers have learned how to harness the power of digital to achieve their key objectives. In this episode of DeviceAlliance’s Medtech Radio, we speak with Chief Operating Officer of TMG360 Media, Kristy Kennedy. TMG360 Media is a Medtech media company focusing on exclusive editorial coverage to influence mainstream media, policymakers, emerging companies, strategics, investors, payers and providers, clinicians, and consumers. Join us as we discuss - The biggest changes medical device companies must consider for their marketing strategies - The new outlook on social media - How the empowered patient will impact consumerization of Medtech - Adding value beyond the device - How upstream and downstream marketing has impacted sales And much more!
/episode/index/show/devicealliancepodcast/id/21743153
info_outline
Axis Research & Technologies: Medtech Training Camp | Ep.46
12/09/2021
Axis Research & Technologies: Medtech Training Camp | Ep.46
/episode/index/show/devicealliancepodcast/id/21426488
info_outline
Dave Saunders: The Present and Future of Medtech AI | Ep.45
11/01/2021
Dave Saunders: The Present and Future of Medtech AI | Ep.45
/episode/index/show/devicealliancepodcast/id/21015590
info_outline
Bryan Starr: Community Investment in Global Medtech | Ep.44
09/27/2021
Bryan Starr: Community Investment in Global Medtech | Ep.44
Irvine is home to over 15,000 businesses, and life sciences and medical device companies constitute one of the fastest-growing sectors. With a global focus on the Medtech industry, the need to build an infrastructure that can support the explosive forecasted growth is more crucial than ever. A well-educated, job-ready workforce, world-renowned R&D facilities and community initiatives all conspire to make Irvine a magnet for Medtech success. So how is Irvine executing on their 50-year plan coming out of the pandemic, to ensure our medical device community is not only a hub of talent and innovation for California, but for the world? In this episode of DeviceAlliance’s Medtech Radio, we speak with the President and CEO at Greater Irvine Chamber of Commerce, Destination Irvine and Irvine Economic Development, Bryan Starr. Join us as we discuss the efforts the Irvine Chamber is making to support the medical device community, their initiatives to attract foreign medical device companies to relocate to Irvine, as how we as a community can engage in local efforts to ensure the thriving success of medical device industry.
/episode/index/show/devicealliancepodcast/id/20618429
info_outline
Live DA Event: Critical Thinking on Clinical Trial Success | Ep.43
08/26/2021
Live DA Event: Critical Thinking on Clinical Trial Success | Ep.43
You’ve got a great idea for a medical device! Now what? Most errors in clinical trials are a result of poor planning. Fancy statistical methods cannot rescue design flaws. Thus careful planning with clear foresight is absolutely crucial for clinical trial success. With the explosion of Medtech opportunities for startups, what are the current best standards for ensuring the success of your design and clinical trials? Join us for this Live-Recorded Podcast Event "Proving Your Device Works in The Real World" as we discuss... - Consideration for the problem you are trying to solve - Big Questions to answer for Clinical Literature, IP Landscape, Stakeholder and Value Proposition, What is relevant today - Pre-clinical / Clinical Testing Feasibility - Planning the Clinical Trial Design – Tactical and Strategic Considerations - Regulatory Pathway & Business Strategy - Design Approach and policy level considerations - The External Environment (Legislative, Healthcare Economics, Orange County Talent, Reimbursement and Market Adoption Expert Panelists Include: Dr. Michael Drues - President of Vascular Sciences & FDA Consultant Jeremy Koehler - Director Of Engineering at NXT Biomedical Vinny Podichetty - VP Clinical & Medical Affairs at JenaValve Technology, Inc. Anand S. Patel, MD - Chief of Interventional Radiology at Providence Little Company of Mary, Torrance Free Opinion Disclaimer The views and opinions expressed at this event are those of the panelists and do not necessarily reflect the official policy or position of their respective organizations. Any content provided by our panelists are of their opinion and are not intended to malign any organization, company, individual or any entity.
/episode/index/show/devicealliancepodcast/id/20273813
info_outline
Hayley Haggarty: Building A Better World | Ep.42
08/03/2021
Hayley Haggarty: Building A Better World | Ep.42
/episode/index/show/devicealliancepodcast/id/20015984
info_outline
Thomas Hopson: Leadership Built to Last | Ep.41
07/12/2021
Thomas Hopson: Leadership Built to Last | Ep.41
What is leadership, anyway? Such a simple question, and yet it continues to vex popular consultants and laypeople alike. Leadership is a process of social influence, which maximizes the efforts of others, towards the achievement of a goal. In this episode of DeviceAlliance’s Medtech Radio, we speak with the President of Bioplatte, Thomas Hopson. Thomas Hopson is an accomplished business executive with over 30 years of experience in the medical device industry. Thomas has provided leadership to multi-million-dollar business enterprises in Europe, Asia, and the United States, and he has successfully transformed multiple struggling organizations into healthy and thriving businesses. He joined Bioplate as President in 2018, bringing with him an extensive background in sales, business development, organizational learning, and product commercialization. Before joining Bioplate, Thomas served as the Director, Global Talent Management & Learning at Edwards Life Sciences. Prior to Edwards, Thomas held various leadership positions at St. Jude Medical. Join us as we discuss his life's journey into leadership, his most valuables mistakes, keeping teams motivated in times of crisis, how to handle making unpopular decisions, and key trends in key trends in the global craniofacial fixation market.
/episode/index/show/devicealliancepodcast/id/19785350
info_outline
Sarah Boundy Wong & Vinny Podichetty: The CRO Selection Blueprint | Ep.43
05/03/2021
Sarah Boundy Wong & Vinny Podichetty: The CRO Selection Blueprint | Ep.43
What are Contract Research Organizations? For any Medtech company, working with CRO’s allow them to outsource work that would otherwise require significant capital to do internally. CRO's let you avoid buying expensive equipment and hiring or training staff for a short-term project. Having independent oversight is critical to ensuring compliance, keeping your clinical research trial on track and bringing your device to market faster. For this reason, many companies hire a clinical research organization (CRO) to monitor, audit, and even manage their trial. Medical device trials in particular bring complex compliance challenges, so having a CRO with specific expertise in this area can be tremendously beneficial. How can you be sure you hire a medical device CRO that is committed to ensuring compliance and is as invested in your success as you are? In this episode of DeviceAlliance’s Medtech Radio, we speak with the Director of Regulatory Affairs at Inari Medical, Sarah Boundy Wong and Vice President Clinical Affairs & Market Dev. at JenaValve Technology, Inc., Vinny Podichetty. Join us as we discuss the best-shared practices and methodologies for selecting a medical device CRO, where does one find CROs, the biggest selection considerations, and lessons learned from both of their professional experiences.
/episode/index/show/devicealliancepodcast/id/18963806
info_outline
Scott Pantel: The Endless Data Challenge | Ep.42
03/15/2021
Scott Pantel: The Endless Data Challenge | Ep.42
COVID-19 has put the MedTech industry at center stage with unparalleled demand for diagnostic tests, personal protective equipment (PPE), ventilators, and other critical medical supplies. In addition to the extraordinary measures underway to rapidly ramp up manufacturing capacity and capabilities, MedTtech companies are also looking outside their normal sector boundaries to explore creative solutions to strategize how they will supplement capacity, open-source equipment design, and address deployment of medically trained employees to support public-health needs. Forward-thinking firms will need data to respond with new products, services, and operating models that can optimize the shifting landscape of healthcare and Medtech development. Join us as talk with the CEO & Founder of LSI, Scott Pantel. In this episode, we discuss the challenges of living in an era of an overabundance of MedTech data and how unique market insights remain an industry challenge. We explore why it's more important than ever for startups and large corporations to make their key strategic decisions based on unique and timely insights. Learn about covid's impact permanently changing the MedTech landscape, and the new considerations the industry must face to address unmet clinical needs.
/episode/index/show/devicealliancepodcast/id/18331421
info_outline
Claudia Graham: Market Access & The Reimbursement Roadmap | Ep.41
02/08/2021
Claudia Graham: Market Access & The Reimbursement Roadmap | Ep.41
/episode/index/show/devicealliancepodcast/id/17871083
info_outline
Dr. Michael Dreus: The Consumerization of MedTech | Ep.40
01/18/2021
Dr. Michael Dreus: The Consumerization of MedTech | Ep.40
For medical device companies, the consumerization of Medtech represents a new paradigm. In the past, medical devices were more targeted toward healthcare providers and payers – now there is a demand for direct-to-consumer products. People are demanding to have more control over their healthcare and they want the ability to proactively manage it. The connected health and wellness devices market is expected to reach $612 billion by 2024, according to a report by Grand View Research Inc. and the wearable medical device market alone is projected to reach $14.41 billion by 2022, according to Markets&Markets Inc. As Medtech explores opportunities within this business model, this consumerization will forever change how healthcare is delivered and medical device evolve. In this episode of DeviceAlliance’s Medtech Radio, we speak with the FDA Consultant and President of Vascular Sciences, Dr. Michael Drues. Join us as we discuss the consumerization of Medtech, defining what is a medical device vs. wellness device with respect to regulation, the "essence" of these distinctions, interpretation of words, and one's ability to defend them in regulation, "Class 0" devices, and wellness devices impact on the evolution of medical devices.
/episode/index/show/devicealliancepodcast/id/17597408
info_outline
Manisha Dhawan: Plotting Your Medtech Career Course | Ep.39
12/14/2020
Manisha Dhawan: Plotting Your Medtech Career Course | Ep.39
/episode/index/show/devicealliancepodcast/id/17193728
info_outline
Dave Ferrera: Innovation in Translation (Replay) | Ep.39
11/30/2020
Dave Ferrera: Innovation in Translation (Replay) | Ep.39
Before one begins any new project, it’s important to understand where you fit into the grand scheme of things. While you may be the person who had the brilliant idea in the first place, that doesn’t mean you know how to lead a company, or build a team, or build a prototype. You can’t be all things to all people. One needs to know what you’re good at, and then you need to know how to hire the best people to fill the positions that you can’t cover. The very first question you should ask is, am I the person who should lead my new company, or do I need to hire a leader who can take my idea and run with it? In this episode of DeviceAlliance’s Medtech Radio, we speak with the Chief Technology Officer at Balt, Dave Ferrera. He also serves as a member of the Board of Advisors to Spinal Singularity, a member of Sage Executive Group, and Chair Orange County American Heart Association Heart & Stroke Ball 2020. Join us as we discuss his upcoming book Innovation in Translation, the critical lessons learned through his early startups, and what it takes to build a team of "A players". Follow the great work Dave and team are doing at Connect with Dave on Dave's Book Recommendation - Thanks for listening! Please share our podcast on LinkedIn, Twitter, and Facebook, and stay tuned for our next episode!
/episode/index/show/devicealliancepodcast/id/17005127
info_outline
Svetla Kibota: The Head and Heart of Medtech Branding | Ep.38
11/16/2020
Svetla Kibota: The Head and Heart of Medtech Branding | Ep.38
Medical device marketing teams are facing unprecedented times as we close out in 2020. As companies emerge from COVID-19 constraints, marketing teams are struggling to refocus their respective work roles and manage the transition back to the workplace. The challenges that marketing teams are facing are more daunting this year than ever. Product launches have been delayed, sales have been lost, and trade shows have been canceled. We’re coming into business planning time and marketing teams will be forced to reckon with the usual “do more with less while at the same time achieving exponential growth” pressures. Only this year, there’s more pressure than ever as teams look at how they can make up for lost time and dollars while managing supplier and manufacturing issues and other critical gaps in infrastructure. Medical device companies have an opportunity to play a role in helping the hospitals solve these challenges that are bigger than the price of the device. By providing needed value-added services and support for hospitals that help address challenges such as infection control, patient throughput, and emergency room wait times, medical device companies can position themselves as indispensable partners. In this episode of DeviceAlliance’s Medtech Radio, we speak with the Founder of Bloom Creative, Svetla Kibota. Svetla has more than twenty years of experience in the pharmaceutical, medical device, and medical technology sectors. She's managed a breadth of medical brands and spearheaded numerous product launches. Prior to founding Bloom Creative, she led the marketing and client services teams at Lathian Health, an interactive medical marketing and medical education agency where she helped recruit clinicians to various digital campaigns. Before that, she worked across Europe and the U.S. for Gilead Sciences and Applied Medical Devices, in both marketing and sales roles. Join us as we discuss... - Essential marketing strategize for Medtech companies - Pivoting from volume to value - The empowered patient model of marketing - Branding for 2021 and beyond - The impact of stories over facts - Optimizing digital communication tools
/episode/index/show/devicealliancepodcast/id/16833008
info_outline
Stan Rowe: The Three Legged Stool | Ep.37
11/02/2020
Stan Rowe: The Three Legged Stool | Ep.37
Deerfield Management and Stan Rowe created a therapeutic device incubator, NXT Biomedical. NXT Biomedical expects to invest up to $25 million in cutting edge technologies over the next 5 years. Deerfield has allotted up to an additional $250 million for the formation and development of five to eight startup companies that emerge from the incubator. NXT Biomedical provides an exciting new pathway for exceptional science to be incubated with the world-renowned leadership while continuing to address major unmet needs with next-generation medical technologies. In this episode of DeviceAlliance’s Medtech Radio, we speak with the Co-Founder & CEO of NXT Biomedical, Stan Rowe. Stan recently retired from Edwards Lifesciences where he was Chief Scientific Officer since 2008 and also served as Corporate Vice President, Advanced Technology. He joined in 2004 when Edwards acquired Percutaneous Valve Technologies, a company he helped to found in 1999 and served as President and CEO. Join us as we discuss Stan's life lessons learned in the Medtech industry, including... - What are the biggest mistakes R&D makes - Growing a company in his bedroom to being acquired - Biggest strategic considerations for innovation - Different types of accelerators - Addressing the future of unmet clinical needs
/episode/index/show/devicealliancepodcast/id/16659107
info_outline
Raymond Cohen: Persevering in OC Medtech (Replay) | Ep.36
10/19/2020
Raymond Cohen: Persevering in OC Medtech (Replay) | Ep.36
In January of 2020, Axonics Modulation Technologies, Inc. announced FDA approval of an enhanced, second-generation Programmer for its r-SNM® System under a premarket approval application supplement. This medtech company has developed and is commercializing novel implantable rechargeable Sacral Neuromodulation (SNM) devices for the treatment of bladder and bowel dysfunction. Axonics has received industry recognition for its technology, including one of FierceMedTech’s Fierce 15 Companies in 2017, 2018 Winner of a Medtech Insight Award: Best Technological Innovation, and a 2019 Finalist for a Medical Design Excellence Award. In this episode of DeviceAlliance’s Medtech Radio, we speak with the CEO of Axonics, Raymond W. Cohen. Raymond is an accredited public company director with over 35 years of experience in leading medical-device companies and serving as a board member at a number of private and publicly traded life science companies. Join us as we discuss his personal journey through medtech leadership as he shares his valuable insights into what it takes to successfully identify market opportunities, create clinical and regulatory strategy, develop viable commercial products, and execute high level strategic planning.
/episode/index/show/devicealliancepodcast/id/16463981
info_outline
PRO-TECH: Designing Workflow | Ep.35
10/05/2020
PRO-TECH: Designing Workflow | Ep.35
Accurate medical device labeling is a critical component to any quality control system. Often though, labeling is only considered at the end of the packaging process, which in itself, is often at the end of medical device design and production. Typically, product engineers develop a device, and only then start to think about how they are going to package and sterilize it. And, then after all that work is done, and typically only after that, do OEMs (original equipment manufacturers) and their contract packaging partners consider the labeling requirements. Yet, many downstream quality issues are the result of incorrect labeling and/or ill-conceived quality controls that do not provide the proper monitoring at each stage. These can result in drastic consequences from the US and/or EU regulatory bodies, and more importantly to the health of the patient. If the wrong components are incorrectly labeled or not labeled at all, the negative downstream effects can be considerable. In this episode of DeviceAlliance’s Medtech Radio, we speak with CEO of Pro-Tech Design and Manufacturing, Pam McMaster, and her son Aaron Swanson President of Pro-Tech Design & manufacturing. PRO-TECH is a family-owned, full-service FDA and ISO 13485 registered medical device contract manufacturer who specializes in medical device assembly and packaging, laboratory services and custom sewn products. Join us as we discuss what most medical device companies forget about, defining and optimizing work flow, the importance of your sterilization method to materials selection, how to navigate an audit during a pandemic, and what opportunities have arisen in this new Medtech environment.
/episode/index/show/devicealliancepodcast/id/16282730
info_outline
Denae Bluethmann: Winning Resumes & Interview Techniques | Ep.34
09/14/2020
Denae Bluethmann: Winning Resumes & Interview Techniques | Ep.34
With the flurry of activity that has been happening in the Medtech industry, having a proper strategy for conducting interviews virtually and in-person is more important than ever. All professionals have engaged in the interview process. However, there is an astonishing lack of effort given to systematic attempts at building improvements into this age-old process. Interviewing remains one of those activities which we think we know all about merely because we have been doing it so long; we have been lulled by habit. It seems apparent that a modest effort aimed at an analysis of our resume writing and interviewing techniques would yield generous returns. Even though most jobs don't require smooth-talking skills, getting through the interview often does. In this episode of DeviceAlliance’s Medtech Radio, we speak with SVP of Recruiting and Development for McDermott & Bull Executive Search, Denae Bluthemann. With 20 years of recruiting experience, she has seen recruiting from all perspectives. She holds an advisory board role for Project Activate, which is an organization that helps individuals at all levels create a path to their dream job. Join us as we discuss the winning techniques for resume writing and job interviews. Topics include... - The most important considerations for virtual interviewing - Addressing resume job and skill gaps effectively - Creating a resume with directional focus and results - Addressing resume job and skill gaps effectively - Why the first five minutes of an interview is absolutely critical - How to best position your "selling points" - The S.T.A.R. method for ensuring interview success - How to close every interview
/episode/index/show/devicealliancepodcast/id/16007690
info_outline
Dr. Keith McCrea: Fighting the Cytokine Storm | Ep.32
08/19/2020
Dr. Keith McCrea: Fighting the Cytokine Storm | Ep.32
/episode/index/show/devicealliancepodcast/id/15669509
info_outline
Taylor McPartland: Entrepreneurial Recipes for Success | Ep. 31
08/03/2020
Taylor McPartland: Entrepreneurial Recipes for Success | Ep. 31
ScaleHealth is an innovation ecosystem focused on connecting great innovators in the health/wellness space, with the strategic resources and partnerships with the goal to impact communities in need. On April 7th ScaleLA formally announced that it will be renamed ScaleHealth, a move which coincides with the announcement to open a 2nd location in Orange County. This location will be launched in partnership with The Innovation Institute, a nationwide leader in healthcare provider innovation, and will be housed at the Innovation Lab in Newport Beach. In this episode of DeviceAlliance’s Medtech Radio, we speak with CEO of ScaleHealth Taylor McPartland. Join us as we discuss his unique background into entrepreneurship, ScaleHealth's mission to build a global health innovation ecosystem, why Orange County was the perfect next step for their strategic growth, and much more!
/episode/index/show/devicealliancepodcast/id/15462866
info_outline
Marinela Gombosev: Developing Soft Skills in Leadership | Ep.30
07/20/2020
Marinela Gombosev: Developing Soft Skills in Leadership | Ep.30
To celebrate our 4th Annual Woman in OC Medtech Event, we will be doing a interview with event panelist Marinela Gombosev. Marinela is CEO of Evoke Neuroscience, a data and diagnostics company focused on reducing the number of people living with treatable cognitive impairment. After immigrating into the United States as a war refugee from Bosnia at the age of 14, she went on to complete her undergraduate studies in Electrical Engineering at the University of California, Irvine and received an MBA from Pepperdine University where she was recognized as a “Top 40 under 40” alumna. In 2015, Marinela was inducted into the University of California, Irvine School of Engineering Hall of Fame as the youngest recipient of this award. She has spent her entire 15 year career in regulated industries, the most recent 10 of which have been in medical devices. In this episode of DeviceAlliance’s Medtech Radio, we discuss her experience coming to the US, the importance of why soft skills in leadership are essential in these times, the impact of Alzhimers's Disease and Evoke Neuroscience's solution for cognitive impairment, what women can do to prepare themselves for success during these times, and much more!
/episode/index/show/devicealliancepodcast/id/15286610
info_outline
Andrew Lyon: Leadership Beyond the Classroom | Ep.29
07/06/2020
Andrew Lyon: Leadership Beyond the Classroom | Ep.29
/episode/index/show/devicealliancepodcast/id/15105236
info_outline
Warren Foust: Leadership Through Authenticity | Ep.28
06/22/2020
Warren Foust: Leadership Through Authenticity | Ep.28
/episode/index/show/devicealliancepodcast/id/14921489